Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel neuroprotective agent developed at Takeda

Sep. 15, 1997

Cardiovascular effects of SB-209509 and sumatriptan compared in dogs

Sep. 15, 1997

Amphetamines may provide long-term benefit in patients with ADHD

Sep. 15, 1997

Kyowa Hakko antiparkinsonian enters phase II trials

Sep. 15, 1997

Preclinical studies show broad antiseizure properties of ganaxolone

Sep. 15, 1997

Capases: a new target for neurodegenerative disease therapy

Sep. 12, 1997

Essential tremor gene located by Icelandic genomics company

Sep. 12, 1997

Focus on Alzheimer's disease research in the U.S.

Sep. 12, 1997

Novartis launches Exelon

Sep. 11, 1997

New atypical antipsychotic agent from HMR

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...